The Pharmaceutical Journal
Vol 269 No 7209 p151
3 August 2002

This article
Reprint
Photocopy

News summary

Related websites
Aids 2002 (more)

Therapeutic vaccine controls HIV

A therapeutic vaccine, Remune, has been shown to stimulate HIV-specific immune responses in 243 HIV infected subjects taking antiretrovirals. The vaccine is being developed by the Immune Response Corp. Data were presented at the 14th International AIDS Conference, held in Barcelona last month.

The researchers say that Remune improves the control of the viral load, increases HIV-specific helper T-cell activity and decreases immune system activation. The three-year phase III study confirms that immunity can be boosted in chronic HIV infection, Dr Fernandez-Cruz, University General Hospital Gergorio Maranon, Madrid, lead researcher, commented.